Severe upper gastrointestinal bleeding remains a common medical emergency.
In the last two decades endoscopy has become the cornerstone of diagnosis,
risk stratification and treatment of peptic ulcer bleeding. Clinical assess
ment and endoscopic recognition of the stigmata of recent haemorrhage can a
llow the identification of patients with a high risk of rebleeding. Patient
s with active bleeding at the time of endoscopy and with non-bleeding visib
le vessels should receive endoscopic treatment, Studies comparing different
treatment modalities are mostly single centre studies with relatively smal
l groups of patients and therefore lack statistical power. furthermore most
of those trials were heterogeneous because of differences in the end point
s, differences in the risk factors for rebleeding and differences in the le
vels of experience of the endoscopists in both recognition and treatment of
bleeding ulcers. Recently different treatment modalities have been studied
. The injection of clot-inducing factors, a combination of injection and th
ermal therapies, repeat endoscopies and the use of mechanical devices such
as clips and ligatures are promising new techniques. However, there are, at
present, no convincing data to suggest that any one of these treatment mod
alities is superior when looking at the overall group of patients with blee
ding peptic ulcer. Larger randomized controlled trials must focus on tailor
ing therapies and using the optimal therapy for different subgroups of pati
ents.